The Institute for OneWorld Health

From Wikipedia, the free encyclopedia

The Institute for OneWorld Heath is a nonprofit pharmaceutical company that was founded in 2000 by Dr. Victoria Hale in San Francisco, California.

Contents

[edit] Drug development efforts

Currently, two drugs are under development a drug to treat Chagas disease in Latin America and a drug to cure visceral leishmaniasis in India. Paromomycin, the drug being developed to treat visceral leishmaniasis, was granted orphan drug status in 2005.

[edit] Executives

[edit] Major supporters

  • Amgen Foundation
  • Bill & Melinda Gates Foundation
  • Chiron Foundation
  • J.P. Morgan Chase Foundation
  • Pfizer Foundation
  • Stanley Thomas Johnson Foundation
  • Sapling Foundation
  • Tillin Foundation
  • Vital Spark Foundation
  • XYZZY Foundation

[edit] External links

[edit] References